These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1711708)

  • 1. [Proteinases, protease inhibitors and antirheumatic therapy].
    Rudenko VG; Rudenko IuV
    Revmatologiia (Mosk); 1990; (3):32-8. PubMed ID: 1711708
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteases, antiproteases, and oxidants: pathways of tissue injury during inflammation.
    Janoff A; Carp H
    Monogr Pathol; 1982; (23):62-82. PubMed ID: 6181397
    [No Abstract]   [Full Text] [Related]  

  • 3. The distribution of enzyme inhibitors in the joint in rheumatoid and experimental arthritis.
    Muirden KD; Leyden K
    Int J Tissue React; 1984; 6(5):359-65. PubMed ID: 6083987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antirheumatic drugs on neutral protease from human leucocyte granules.
    Kruze D; Fehr K; Menninger H; Böni A
    Z Rheumatol; 1976; 35(9-10):337-46. PubMed ID: 136142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The activity of trypsin-like proteinases and their inhibitors inpatients with tuberculosis of bones and joints].
    Titarenko OT; Esmedliaeva DS; Sadovoĭ MIa; Momot DS
    Probl Tuberk; 1991; (2):56-9. PubMed ID: 1709731
    [No Abstract]   [Full Text] [Related]  

  • 6. Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.
    Vissers MC; George PM; Bathurst IC; Brennan SO; Winterbourn CC
    J Clin Invest; 1988 Aug; 82(2):706-11. PubMed ID: 2841359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Character of changes in protease inhibitory capacity of blood in experimental osteoarticular tuberculosis].
    Titarenko OT; Esmedliaeva DS; Nakonechnyĭ GD; Momot DS; Perova TL
    Vopr Med Khim; 1992; 38(1):16-8. PubMed ID: 1279893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The alpha-1 fractions in inflammatory states. Correlations between alpha-1-antitrypsin and/acid alpha-1-glycoprotein].
    Troise W; Buticchi G; Sesenna G; Ambanelli U
    Boll Soc Ital Biol Sper; 1975 Sep; 51(17):1059-62. PubMed ID: 56181
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of protease inhibitors on the anti-enzymatic and surface activities of bronchoalveolar contents in infectious-toxic shock].
    Protsenko VA; Opryshko VV; Shpak SI; Nesterov EN; Safronova LG
    Patol Fiziol Eksp Ter; 1984; (6):49-52. PubMed ID: 6084229
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protease inhibitors of the synovial fluid in the pathogenesis and diagnosis of joint diseases].
    Rudenko VG
    Vrach Delo; 1987 Oct; (10):37-40. PubMed ID: 2447703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proteinase-proteinase inhibitor complex in rats under oxidative stress caused by administration of cobalt chloride].
    Kaliman PA; Samokhin AA; Samokhina LM
    Ukr Biokhim Zh (1999); 2000; 72(1):89-92. PubMed ID: 10979565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous anti-inflammatory proteins.
    Lewis DA
    Biochem Pharmacol; 1977 Apr; 26(8):693-8. PubMed ID: 67845
    [No Abstract]   [Full Text] [Related]  

  • 13. Elimination of protease-inhibitor complexes from the arthritic joint.
    Ekerot L; Ohlsson K; Necking L
    Int J Tissue React; 1985; 7(5):391-5. PubMed ID: 2414244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of neutrophils in the pathogenesis of rheumatoid arthritis and their changes as affected by anti-rheumatic agents].
    Malinovskaia EI
    Revmatologiia (Mosk); 1988; (2):63-8. PubMed ID: 3051279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the proteinase inhibitor alpha 2-macroglobulin in synovial fluids of arthritis of different origins and its relation to serologic parameters].
    Borth W; Menzel EJ; Kubin A; Dunky A; Heckl F
    Wien Klin Wochenschr; 1983 Dec; 95(24):873-7. PubMed ID: 6199906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical basis for using proteolysis inhibitors in inflammatory processes of the cornea].
    Chesnokova NB; Kasavina BS; Shchipanova AI
    Vestn Oftalmol; 1983; (1):48-50. PubMed ID: 6187116
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibronectin and other immunologic parameters in chronic polyarthritis].
    Siegmeth W; Minar E; Graninger W; Pirich K; Zazgornik J
    Z Rheumatol; 1984; 43(1):27-9. PubMed ID: 6201023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of the blood sialic acid and acute phase reactant levels in chronic rheumatoid arthritis].
    Warabi H; Yamada E; Shiokawa Y
    Rinsho Byori; 1983 Mar; Suppl 54():113-9. PubMed ID: 6193298
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitrypsin activity and enzyme inhibitors in the rheumatoid joint.
    Robinson AD; Boyden KN; Hendrickson SM; Muirden KD
    J Rheumatol; 1981; 8(4):547-54. PubMed ID: 6170754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.